67 related articles for article (PubMed ID: 29579207)
21. Mexican Cervical Cancer Screening Study II: 6-month and 2-year follow-up of HR-HPV women treated with cryotherapy in a low-resource setting.
Starks D; Arriba LN; Enerson CL; Brainard J; Nagore N; Chiesa-Vottero A; Uribe JV; Belinson J
J Low Genit Tract Dis; 2014 Oct; 18(4):333-7. PubMed ID: 24977628
[TBL] [Abstract][Full Text] [Related]
22. Is screen-and-treat approach suited for screening and management of precancerous cervical lesions in Sub-Saharan Africa?
Fokom-Domgue J; Vassilakos P; Petignat P
Prev Med; 2014 Aug; 65():138-40. PubMed ID: 24879892
[TBL] [Abstract][Full Text] [Related]
23. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador.
Cremer ML; Maza M; Alfaro KM; Kim JJ; Ditzian LR; Villalta S; Alonzo TA; Felix JC; Castle PE; Gage JC
J Low Genit Tract Dis; 2016 Apr; 20(2):145-50. PubMed ID: 26890683
[TBL] [Abstract][Full Text] [Related]
24. Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities.
DeGregorio G; Manga S; Kiyang E; Manjuh F; Bradford L; Cholli P; Wamai R; Ogembo R; Sando Z; Liu Y; Sheldon LK; Nulah K; Welty T; Welty E; Ogembo JG
Oncologist; 2017 Jul; 22(7):850-859. PubMed ID: 28536303
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India.
Basu P; Mittal S; Banerjee D; Singh P; Panda C; Dutta S; Mandal R; Das P; Biswas J; Muwonge R; Sankaranarayanan R
Int J Cancer; 2015 Aug; 137(4):859-67. PubMed ID: 25631198
[TBL] [Abstract][Full Text] [Related]
26. Experience of a 'Screen and treat' program for secondary prevention of cervical cancer in Uttar Pradesh, India.
Shikha S; Smita J; Nayanjeet C; Ruchi P; Parul S; Uma M; Shubhra T; Phillip G; Pritpal M
J Obstet Gynaecol Res; 2020 Feb; 46(2):320-327. PubMed ID: 31814247
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
Campos NG; Castle PE; Wright TC; Kim JJ
Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus screening and cervical cancer prevention.
Sasieni PD
J Am Med Womens Assoc (1972); 2000; 55(4):216-9. PubMed ID: 10935355
[TBL] [Abstract][Full Text] [Related]
29. One-year follow-up of single-visit approach to cervical cancer prevention based on visual inspection with acetic acid wash and immediate cryotherapy in rural Thailand.
Chumworathayi B; Srisupundit S; Lumbiganon P; Limpaphayom KK
Int J Gynecol Cancer; 2008; 18(4):736-42. PubMed ID: 17949424
[TBL] [Abstract][Full Text] [Related]
30. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for cervical cancer among distinct populations in low-resource countries: feasibility of cervical cancer screen-and-treat program on ukerewe island of lake victoria, Tanzania.
Hari AY; Bernstein M; Temko J; Brabender DE; Shen A; Tewari KS
Curr Opin Obstet Gynecol; 2022 Feb; 34(1):20-27. PubMed ID: 34967811
[TBL] [Abstract][Full Text] [Related]
32. Change in Provider Beliefs Regarding Cervical Cancer Screening Intervals After an Educational Intervention.
Benard VB; Greek A; Roland KB; Hawkins NA; Lin L; Saraiya M
J Womens Health (Larchmt); 2016 May; 25(5):422-7. PubMed ID: 27096534
[TBL] [Abstract][Full Text] [Related]
33. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
34. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of community-based careHPV for cervical cancer prevention in rural Thailand.
Trope LA; Chumworathayi B; Blumenthal PD
J Low Genit Tract Dis; 2013 Jul; 17(3):315-9. PubMed ID: 23422644
[TBL] [Abstract][Full Text] [Related]
36. Cost-Utility Analysis of Human Papillomavirus Vaccination and Cervical Screening on Cervical Cancer Patient in Indonesia.
Setiawan D; Dolk FC; Suwantika AA; Westra TA; WIlschut JC; Postma MJ
Value Health Reg Issues; 2016 May; 9():84-92. PubMed ID: 27881267
[TBL] [Abstract][Full Text] [Related]
37. Feasibility, acceptability, and effectiveness of visual inspection of the cervix with acetic acid and cryotherapy for dysplasia in Nigeria.
Adefuye PO; Dada OA; Adefuye BO; Shorunmu TO; Akinyemi BO; Idowu-Ajiboye BO
Int J Gynaecol Obstet; 2015 Apr; 129(1):62-6. PubMed ID: 25593107
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the clinical performance of high-risk human papillomavirus testing for primary screening: a retrospective review of the Southern California Permanente Medical Group experience.
Lonky NM; Mahdavi A; Wolde-Tsadik G; Bajamundi K; Felix JC
J Low Genit Tract Dis; 2010 Jul; 14(3):200-5. PubMed ID: 20592555
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country.
Nuranna L; Aziz MF; Cornain S; Purwoto G; Purbadi S; Budiningsih S; Siregar B; Peters AA
J Gynecol Oncol; 2012 Jul; 23(3):147-52. PubMed ID: 22808356
[TBL] [Abstract][Full Text] [Related]
40. Diagnosing cervical dysplasia using visual inspection of the cervix with acetic acid in a woman in rural Haiti.
Roger E; Nwosu O
Int J Environ Res Public Health; 2014 Nov; 11(12):12304-11. PubMed ID: 25464128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
